News Headline Summary
Medtronic (MDT) says the first patient is being treated in Medtronic clinical trial evaluating corevalue system in intermediate-risk patients
Reaction details:
- Medtronic shares unmoved by this latest news; trades USD 41.12 last (+0.6%).
Print
19:00, 16 Nov 2012 -
US Equities
- Source:
Newswires
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
-
Real-time audio coverage from 0630 to 2130 London time
-
Teams of analysts covering equities, fixed income, FX and energy markets
-
Real-time scrolling news service
-
Daily and weekly pre-market research and calendars
-
Intra-day market update videos
-
Daily technical analysis